tiprankstipranks
SkinBioTherapeutics PLC (GB:SBTX)
LSE:SBTX
UK Market

SkinBioTherapeutics (SBTX) Cash flow

Compare
11 Followers

SkinBioTherapeutics Cash Flow

GB:SBTX's free cash flow for Q2 2023 was £-1.38M. For the 2023 fiscal year, GB:SBTX's free cash flow was decreased by £-114.07K and operating cash flow was £-1.37M. See a summary of the company’s cash flow.
Cash Flow
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
£ -2.73M£ -2.65M£ -2.67M£ -1.56M£ -892.14K
Investing Cash Flow
£ -2.30M£ -165.28K£ -96.81K£ -112.31K£ -73.67K
Financing Cash Flow
£ 4.51M£ 2.32M£ -35.12K£ 4.12M£ 0.00
End Cash Position
£ 800.90K£ 1.31M£ 1.80M£ 4.61M£ 2.16M
Free Cash Flow
£ -2.92M£ -2.81M£ -2.77M£ -1.67M£ -965.80K
Currency in GBP

SkinBioTherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis